Anderson J. Ryan

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel et al. · Journal of Clinical Oncology · 2011 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +6

ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.

Francesca Carlomagno, Donata Vitagliano, Teresa Guida et al. · PubMed · 2002 · 570 citations

Medicine, Oncology, Pharmacology +17

Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation

Sophia X. Pfister, Enni Markkanen, Yanyan Jiang et al. · Cancer Cell · 2015 · 309 citations · Full text

Medicine, Cancer Biology, Oncology +12

Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds

J. Zimmer, Eliana MC Tacconi, Cecilia Folio et al. · Molecular Cell · 2015 · 263 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors

Francesca Carlomagno, Teresa Guida, Suresh Anaganti et al. · Oncogene · 2004 · 254 citations

Medicine, Genetics, Molecular Genetics +12